KTTA · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2023-08-11 compared with 2023-05-12 · 7 added, 0 removed, 27 unchanged (21% of the section changed)
Other Information.
+Added: Offer of Employment, dated as of June 21, 2022, between Pasithea Therapeutics Corp.
+Added: Graeme Currie.
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
Furnished, not filed.
+Added: Indicates a management contract or any compensatory plan, contract or arrangement.
+Added: identified information has been excluded from this exhibit (indicated by asterisks) because it is both not material and the type of information
+Added: that the Company treats as private or confidential, in accordance with the rules of the SEC.
Pursuant to the requirements
6 unchanged sentences
(Principal Executive Officer)
+Added: August 11, 2023
/s/ Daniel Schneiderman
3 unchanged sentences
Principal Accounting Officer)
+Added: August 11, 2023
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.